HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protective effect of novel substituted nicotine hydrazide analogues against hypoxic brain injury in neonatal rats via inhibition of caspase.

Abstract
In hypoxic-ischemic injury of the brain of neonates, the level of caspase-3 was found to be aberrantly activated. Its overexpression leads to the alteration of cytoskeleton protein fodrin and loss of DNA repair enzyme which ultimately results in neurological impairment and disability. Concerning this, the present study was intended to develop novel nicotine hydrazide analogues as caspase inhibitors via efficient synthetic route. These compounds were subsequently tested for inhibitory activity against caspase-3 and -7 where they exhibit highly potent activity against caspase-3 revealing compound 5k as most potent inhibitor (IC50=19.4±2.5μM). In Western blot analysis, 5k considerably inhibits the overexpression of caspase-3. The aryl nicotinate of compound 5k, as indicated by molecular docking was found to engage His121 and critical enzyme thiols, i.e., Cys163 of caspase-3 for its potent activity. Moreover, histopathological examination of brain tissues and hippocampus neurons showed that compound 5k considerably improves the brain injury and exert neuroprotective effects in hypoxic-ischemic (HI). In brain homogenate, 5k significantly improves the activity of MDA, SOD, GSH-Px, CAT and T-AOC to exert its beneficial effect against oxidative stress induced by HI injury.
AuthorsChang-Bo Deng, Juan Li, Lu-Yi Li, Feng-Jie Sun
JournalBioorganic & medicinal chemistry letters (Bioorg Med Chem Lett) Vol. 26 Issue 13 Pg. 3195-3201 (07 01 2016) ISSN: 1464-3405 [Electronic] England
PMID27216999 (Publication Type: Journal Article)
CopyrightCopyright © 2016 Elsevier Ltd. All rights reserved.
Chemical References
  • Caspase Inhibitors
  • Neuroprotective Agents
  • nicotine hydrazide
  • Nicotine
  • Caspase 3
  • Caspase 7
Topics
  • Animals
  • Caspase 3 (metabolism)
  • Caspase 7 (metabolism)
  • Caspase Inhibitors (chemical synthesis, chemistry, pharmacology)
  • Dose-Response Relationship, Drug
  • Hypoxia-Ischemia, Brain (drug therapy, metabolism)
  • Molecular Structure
  • Neuroprotective Agents (chemical synthesis, chemistry, pharmacology)
  • Nicotine (analogs & derivatives, chemical synthesis, chemistry, pharmacology)
  • Rats
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: